Copyright Reports & Markets. All rights reserved.

Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Monotherapy
      • 1.4.3 Combination Therapy
    • 1.5 Market by Application
      • 1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application (2014-2025)
      • 1.5.2 Hematologic Malignancies
      • 1.5.3 Solid Malignancies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 CAR T-Cell Immunotherapy Market Size
    • 2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
      • 2.2.1 CAR T-Cell Immunotherapy Market Size by Regions (2014-2025)
      • 2.2.2 CAR T-Cell Immunotherapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 CAR T-Cell Immunotherapy Market Size by Manufacturers
      • 3.1.1 Global CAR T-Cell Immunotherapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 CAR T-Cell Immunotherapy Key Players Head office and Area Served
    • 3.3 Key Players CAR T-Cell Immunotherapy Product/Solution/Service
    • 3.4 Date of Enter into CAR T-Cell Immunotherapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global CAR T-Cell Immunotherapy Market Size by Type (2014-2019)
    • 4.2 Global CAR T-Cell Immunotherapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 5.2 CAR T-Cell Immunotherapy Key Players in United States
    • 5.3 United States CAR T-Cell Immunotherapy Market Size by Type
    • 5.4 United States CAR T-Cell Immunotherapy Market Size by Application

    6 Europe

    • 6.1 Europe CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 6.2 CAR T-Cell Immunotherapy Key Players in Europe
    • 6.3 Europe CAR T-Cell Immunotherapy Market Size by Type
    • 6.4 Europe CAR T-Cell Immunotherapy Market Size by Application

    7 China

    • 7.1 China CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 7.2 CAR T-Cell Immunotherapy Key Players in China
    • 7.3 China CAR T-Cell Immunotherapy Market Size by Type
    • 7.4 China CAR T-Cell Immunotherapy Market Size by Application

    8 Japan

    • 8.1 Japan CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 8.2 CAR T-Cell Immunotherapy Key Players in Japan
    • 8.3 Japan CAR T-Cell Immunotherapy Market Size by Type
    • 8.4 Japan CAR T-Cell Immunotherapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 9.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia
    • 9.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type
    • 9.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application

    10 India

    • 10.1 India CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 10.2 CAR T-Cell Immunotherapy Key Players in India
    • 10.3 India CAR T-Cell Immunotherapy Market Size by Type
    • 10.4 India CAR T-Cell Immunotherapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America CAR T-Cell Immunotherapy Market Size (2014-2019)
    • 11.2 CAR T-Cell Immunotherapy Key Players in Central & South America
    • 11.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type
    • 11.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application

    12 International Players Profiles

    • 12.1 AbbVie
      • 12.1.1 AbbVie Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 CAR T-Cell Immunotherapy Introduction
      • 12.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.1.5 AbbVie Recent Development
    • 12.2 Celgene
      • 12.2.1 Celgene Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 CAR T-Cell Immunotherapy Introduction
      • 12.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.2.5 Celgene Recent Development
    • 12.3 Kite Pharma
      • 12.3.1 Kite Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 CAR T-Cell Immunotherapy Introduction
      • 12.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.3.5 Kite Pharma Recent Development
    • 12.4 Oxford BioMedica
      • 12.4.1 Oxford BioMedica Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 CAR T-Cell Immunotherapy Introduction
      • 12.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.4.5 Oxford BioMedica Recent Development
    • 12.5 Novartis
      • 12.5.1 Novartis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 CAR T-Cell Immunotherapy Introduction
      • 12.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.5.5 Novartis Recent Development
    • 12.6 Gilead
      • 12.6.1 Gilead Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 CAR T-Cell Immunotherapy Introduction
      • 12.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.6.5 Gilead Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 CAR T-Cell Immunotherapy Introduction
      • 12.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.7.5 Pfizer Recent Development
    • 12.8 Cellectis
      • 12.8.1 Cellectis Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 CAR T-Cell Immunotherapy Introduction
      • 12.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.8.5 Cellectis Recent Development
    • 12.9 Bellicum
      • 12.9.1 Bellicum Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 CAR T-Cell Immunotherapy Introduction
      • 12.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.9.5 Bellicum Recent Development
    • 12.10 Mustang Bio
      • 12.10.1 Mustang Bio Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 CAR T-Cell Immunotherapy Introduction
      • 12.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2014-2019)
      • 12.10.5 Mustang Bio Recent Development
    • 12.11 CARsgen Therapeutics
    • 12.12 Xyphos
    • 12.13 Minerva Biotechnologies
    • 12.14 Adaptimmune
    • 12.15 Ziopharm Oncology
    • 12.16 Aurora Biopharma
    • 12.17 Creative Biolabs

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
      In 2018, the global CAR T-Cell Immunotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Immunotherapy development in United States, Europe and China.

      The key players covered in this study
      AbbVie
      Celgene
      Kite Pharma
      Oxford BioMedica
      Novartis
      Gilead
      Pfizer
      Cellectis
      Bellicum
      Mustang Bio
      CARsgen Therapeutics
      Xyphos
      Minerva Biotechnologies
      Adaptimmune
      Ziopharm Oncology
      Aurora Biopharma
      Creative Biolabs

      Market segment by Type, the product can be split into
      Monotherapy
      Combination Therapy

      Market segment by Application, split into
      Hematologic Malignancies
      Solid Malignancies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players.
      To present the CAR T-Cell Immunotherapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of CAR T-Cell Immunotherapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now